{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:55:58Z","timestamp":1779335758888,"version":"3.51.4"},"reference-count":139,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:p>The heart and the liver display multifaceted, complex interactions that can be divided into cardiac effects of liver disease, hepatic effects of heart disease, and disease processes affecting both organs. In part 1 of this 2 part series, we discuss how acute and chronic heart failure can have devastating effects on the liver, such as acute cardiogenic liver injury and congestive hepatopathy. On the other hand, primary liver disease, such as cirrhosis, can lead to a plethora of cardiac insults representative in cirrhotic cardiomyopathy as systolic dysfunction, diastolic dysfunction, and electrophysiological disturbances. Nonalcoholic fatty liver disease has long been associated with cardiovascular events that increase mortality. The management of both disease processes changes when the other organ system becomes involved. This consideration is important with regard to a variety of interventions, most notably transplantation of either organ, as risk of complications dramatically rises in the setting of both heart and liver disease (discussed in part 2). As our understanding of the intricate communication between the heart and liver continues to expand so does our management.<\/jats:p>","DOI":"10.1097\/crd.0000000000000379","type":"journal-article","created":{"date-parts":[[2020,12,19]],"date-time":"2020-12-19T06:00:43Z","timestamp":1608357643000},"page":"111-122","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Part 1: Disease of the Heart and Liver"],"prefix":"10.1097","volume":"30","author":[{"given":"Nicholas","family":"Scalzo","sequence":"first","affiliation":[{"name":"From the Department of Medicine, Section of Gastroenterology & Hepatobiliary Diseases, New York Medical College and Westchester Medical Center, Valhalla, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehtap","family":"Canastar","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Section of Gastroenterology & Hepatobiliary Diseases, New York Medical College and Westchester Medical Center, Valhalla, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Lebovics","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Section of Gastroenterology & Hepatobiliary Diseases, New York Medical College and Westchester Medical Center, Valhalla, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,12,17]]},"reference":[{"key":"R1-20250619","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics-2019 update: a Report From the American Heart Association.","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"R2-20250619","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/CIRCRESAHA.113.300268","article-title":"Epidemiology of heart failure.","volume":"113","author":"Roger","year":"2013","journal-title":"Circ Res"},{"key":"R4-20250619","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1093\/eurheartj\/eht246","article-title":"Interactions of the heart and the liver.","volume":"34","author":"M\u00f8ller","year":"2013","journal-title":"Eur Heart J"},{"key":"R5-20250619","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1007\/s10620-016-4040-6","article-title":"Cardiovascular disease and myocardial abnormalities in nonalcoholic fatty liver disease.","volume":"61","author":"Mantovani","year":"2016","journal-title":"Dig Dis Sci"},{"key":"R6-20250619","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jchf.2018.10.007","article-title":"Heart failure and liver disease: cardiohepatic interactions.","volume":"7","author":"Xanthopoulos","year":"2019","journal-title":"JACC Heart Fail"},{"key":"R7-20250619","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/cld.581","article-title":"Liver fibrosis: which mechanisms matter?","volume":"8","author":"Weiskirchen","year":"2016","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"R8-20250619","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/cmi.2011.53","article-title":"Liver fibrosis: mechanisms of immune-mediated liver injury.","volume":"9","author":"Xu","year":"2012","journal-title":"Cell Mol Immunol"},{"key":"R9-20250619","doi-asserted-by":"crossref","first-page":"F1000 Faculty Rev-921","DOI":"10.12688\/f1000research.14841.1","article-title":"Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts.","volume":"7","author":"Weiskirchen","year":"2018","journal-title":"F1000Res"},{"key":"R10-20250619","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/cld.676","article-title":"Congestive hepatopathy: differentiating congestion from fibrosis.","volume":"10","author":"Lemmer","year":"2017","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"R11-20250619","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/hep.30048","article-title":"Assessment of advanced liver fibrosis and the risk for hepatic decompensation in patients with congestive hepatopathy.","volume":"68","author":"Lemmer","year":"2018","journal-title":"Hepatology"},{"key":"R12-20250619","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3390\/cells1041261","article-title":"Signals and cells involved in regulating liver regeneration.","volume":"1","author":"Kang","year":"2012","journal-title":"Cells"},{"key":"R13-20250619","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.gtc.2017.01.012","article-title":"Heart disease and the liver. In: Lefkowitch J, ed.","volume":"426","author":"Koehne de Gonzalez","year":"2017","journal-title":"Gastroenterol Clinics North Am"},{"key":"R14-20250619","first-page":"447","article-title":"Chronic passive congestion of the liver in man. Electron microscopic study of cell atrophy and intralobular fibrosis.","volume":"50","author":"Safran","year":"1967","journal-title":"Am J Pathol"},{"key":"R16-20250619","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/cld.573","article-title":"Congestive hepatopathy.","volume":"8","author":"Hilscher","year":"2016","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"R17-20250619","doi-asserted-by":"crossref","first-page":"197","DOI":"10.5152\/tjg.2015.0086","article-title":"How to interpret liver function tests in heart failure patients?","volume":"26","author":"\u00c7a\u011fli","year":"2015","journal-title":"Turk J Gastroenterol"},{"key":"R18-20250619","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0016-5085(78)90300-1","article-title":"Left-sided heart failure presenting as hepatitis.","volume":"74","author":"Cohen","year":"1978","journal-title":"Gastroenterology"},{"key":"R19-20250619","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejim.2017.10.016","article-title":"Liver disease and heart failure: back and forth.","volume":"48","author":"Correale","year":"2018","journal-title":"Eur J Intern Med"},{"key":"R20-20250619","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4254\/wjh.v5.i5.251","article-title":"Cirrhotic ascites review: pathophysiology, diagnosis and management.","volume":"5","author":"Moore","year":"2013","journal-title":"World J Hepatol"},{"key":"R21-20250619","doi-asserted-by":"crossref","first-page":"801, vii","DOI":"10.1016\/j.mcna.2009.03.007","article-title":"Ascites: diagnosis and management.","volume":"93","author":"Hou","year":"2009","journal-title":"Med Clin North Am"},{"key":"R22-20250619","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1432-2277.2005.00122.x","article-title":"Cardiac hepatopathy before and after heart transplantation.","volume":"18","author":"Dichtl","year":"2005","journal-title":"Transpl Int"},{"key":"R23-20250619","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1148\/rg.2016150207","article-title":"Imaging findings of congestive hepatopathy.","volume":"36","author":"Wells","year":"2016","journal-title":"Radiographics"},{"key":"R24-20250619","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1590\/S0066-782X2007000500015","article-title":"Clinical evaluation and hepatic laboratory assessment in individuals with congestive heart failure.","volume":"88","author":"Vasconcelos","year":"2007","journal-title":"Arq Bras Cardiol"},{"key":"R25-20250619","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.cardfail.2011.02.012","article-title":"\u03b3-Glutamyltransferase rather than total bilirubin predicts outcome in chronic heart failure.","volume":"17","author":"Ess","year":"2011","journal-title":"J Card Fail"},{"key":"R26-20250619","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2005.08.022","article-title":"ACC\/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure).","volume":"46","author":"Hunt","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R27-20250619","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines.","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R28-20250619","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"R29-20250619","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-0031-1284434","article-title":"Liver abnormalities in cardiac diseases and heart failure.","volume":"20","author":"Alvarez","year":"2011","journal-title":"Int J Angiol"},{"key":"R30-20250619","first-page":"2223","article-title":"Special considerations in interpreting liver function tests.","volume":"59","author":"Johnston","year":"1999","journal-title":"Am Fam Physician"},{"key":"R31-20250619","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1053\/gast.2002.36061","article-title":"AGA technical review on the evaluation of liver chemistry tests.","volume":"123","author":"Green","year":"2002","journal-title":"Gastroenterology"},{"key":"R32-20250619","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/eurjhf\/hfn031","article-title":"Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program.","volume":"11","author":"Allen","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"R33-20250619","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.revmed.2013.12.001","article-title":"[Non-cirrhotic ascites: pathophysiology, diagnosis and etiology].","volume":"35","author":"Carrier","year":"2014","journal-title":"Rev Med Interne"},{"key":"R34-20250619","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.3748\/wjg.v25.i28.3738","article-title":"Current approaches to the management of patients with cirrhotic ascites.","volume":"25","author":"Garbuzenko","year":"2019","journal-title":"World J Gastroenterol"},{"key":"R35-20250619","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00004836-198808000-00013","article-title":"Cardiac ascites: a characterization.","volume":"10","author":"Runyon","year":"1988","journal-title":"J Clin Gastroenterol"},{"key":"R37-20250619","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jtcvs.2016.10.060","article-title":"Liver health in adults with Fontan circulation: a multicenter cross-sectional study.","volume":"153","author":"Wu","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R38-20250619","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1097\/MCG.0b013e318198113b","article-title":"Usefulness of serum N-terminal-ProBNP in distinguishing ascites due to cirrhosis from ascites due to heart failure.","volume":"44","author":"Sheer","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"R39-20250619","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1080\/00365521.2017.1323230","article-title":"Characterization of ascites in cardiac cirrhosis: the value of ascitic fluid protein to screen for concurrent cardiac cirrhosis.","volume":"52","author":"Wang","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"R40-20250619","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1148\/rg.2017160161","article-title":"A comprehensive approach to hepatic vascular disease.","volume":"37","author":"Elsayes","year":"2017","journal-title":"Radiographics"},{"key":"R41-20250619","first-page":"711","article-title":"XXIX. The anatomy and physiology of the liver. In: Green JH, ed.","volume":"123","author":"Kiernan","year":"1833","journal-title":"The Royal Society"},{"key":"R42-20250619","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/hrt.13.3.273","article-title":"The liver in heart failure; relation of anatomical, functional, and circulatory changes.","volume":"13","author":"Sherlock","year":"1951","journal-title":"Br Heart J"},{"key":"R43-20250619","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.3748\/wjg.v20.i7.1724","article-title":"Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease.","volume":"20","author":"Ballestri","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R45-20250619","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/CIRCHEARTFAILURE.108.821199","article-title":"Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist?","volume":"2","author":"Bansal","year":"2009","journal-title":"Circ Heart Fail"},{"key":"R46-20250619","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.3748\/wjg.15.3631","article-title":"Spot urinary sodium for assessing dietary sodium restriction in cirrhotic ascites.","volume":"15","author":"El-Bokl","year":"2009","journal-title":"World J Gastroenterol"},{"key":"R47-20250619","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/jhep.2003.50021","article-title":"A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial.","volume":"37","author":"Wong","year":"2003","journal-title":"Hepatology"},{"key":"R48-20250619","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/gutjnl-2011-300157","article-title":"Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity.","volume":"61","author":"Wong","year":"2012","journal-title":"Gut"},{"key":"R49-20250619","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/hep.26359","article-title":"Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012.","volume":"57","author":"Runyon","year":"2013","journal-title":"Hepatology"},{"key":"R50-20250619","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/hep.22853","article-title":"Management of adult patients with ascites due to cirrhosis: an update.","volume":"49","author":"Runyon","year":"2009","journal-title":"Hepatology"},{"key":"R51-20250619","first-page":"350","article-title":"Gibbs memorial lecture. Unifying hypothesis of body fluid volume regulation: implications for cardiac failure and cirrhosis.","volume":"68","author":"Schrier","year":"2001","journal-title":"Mt Sinai J Med"},{"key":"R52-20250619","doi-asserted-by":"crossref","first-page":"6046","DOI":"10.3748\/wjg.v16.i48.6046","article-title":"Regulation of hepatic blood flow: the hepatic arterial buffer response revisited.","volume":"16","author":"Eipel","year":"2010","journal-title":"World J Gastroenterol"},{"key":"R53-20250619","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3390\/cells9030567","article-title":"Relationship between heart disease and liver disease: a two-way street.","volume":"9","author":"El Hadi","year":"2020","journal-title":"Cells"},{"key":"R54-20250619","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/01.md.0000101573.54295.bd","article-title":"Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases.","volume":"82","author":"Henrion","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"R55-20250619","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1067\/mhj.2000.107177","article-title":"Heart diseases affecting the liver and liver diseases affecting the heart.","volume":"140","author":"Naschitz","year":"2000","journal-title":"Am Heart J"},{"key":"R56-20250619","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.trre.2014.11.003","article-title":"Liver disease related to the heart.","volume":"29","author":"Ford","year":"2015","journal-title":"Transplant Rev (Orlando)"},{"key":"R57-20250619","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1001\/archinte.1987.00370070041006","article-title":"Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics.","volume":"147","author":"Kubo","year":"1987","journal-title":"Arch Intern Med"},{"key":"R58-20250619","first-page":"263","article-title":"Hypoxic hepatitis: a review and clinical update.","volume":"4","author":"Waseem","year":"2016","journal-title":"J Clin Transl Hepatol"},{"key":"R59-20250619","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/hep.25692","article-title":"Congenital heart disease and the liver.","volume":"56","author":"Asrani","year":"2012","journal-title":"Hepatology"},{"key":"R60-20250619","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jjcc.2019.02.016","article-title":"Fontan-associated liver disease: a review.","volume":"74","author":"Gordon-Walker","year":"2019","journal-title":"J Cardiol"},{"key":"R61-20250619","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1172\/JCI102813","article-title":"The cardiac output at rest in Laennec\u2019s cirrhosis.","volume":"32","author":"Kowalski","year":"1953","journal-title":"J Clin Invest"},{"key":"R62-20250619","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/17474124.2019.1587293","article-title":"An update on cirrhotic cardiomyopathy.","volume":"13","author":"M\u00f8ller","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R63-20250619","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0168-8278(96)80272-8","article-title":"Cardiac modifications occurring in the ascitic rat with biliary cirrhosis are nitric oxide related.","volume":"24","author":"van Obbergh","year":"1996","journal-title":"J Hepatol"},{"key":"R64-20250619","doi-asserted-by":"crossref","first-page":"H1689","DOI":"10.1152\/ajpheart.00538.2007","article-title":"Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats.","volume":"293","author":"B\u00e1tkai","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"suppl 1","key":"R65-20250619","first-page":"A475","article-title":"Prevalence of diastolic dysfunction in cirrhosis and its clinical significance. In: Villamil A, ed.","volume":"54","author":"Wong","year":"2011","journal-title":"Hepatology"},{"key":"R66-20250619","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/MCG.0000000000000323","article-title":"High rate of cardiac abnormalities in a postmortem analysis of patients suffering from liver cirrhosis.","volume":"49","author":"Wehmeyer","year":"2015","journal-title":"J Clin Gastroenterol"},{"key":"R67-20250619","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jhep.2011.02.030","article-title":"Role of cardiac myofilament proteins titin and collagen in the pathogenesis of diastolic dysfunction in cirrhotic rats.","volume":"55","author":"Glenn","year":"2011","journal-title":"J Hepatol"},{"key":"R68-20250619","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-4939-7113-8_19","article-title":"Type I collagen purification from rat tail tendons.","volume":"1627","author":"Ritti\u00e9","year":"2017","journal-title":"Methods Mol Biol"},{"key":"R69-20250619","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s12072-014-9544-6","article-title":"Diastolic cardiac dysfunction is a predictor of dismal prognosis in patients with liver cirrhosis.","volume":"8","author":"Karagiannakis","year":"2014","journal-title":"Hepatol Int"},{"key":"R70-20250619","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/0961203307087303","article-title":"E\/E\u2019 ratio is more sensitive than E\/A ratio for detection of left ventricular diastolic dysfunction in systemic lupus erythematosus.","volume":"17","author":"Lee","year":"2008","journal-title":"Lupus"},{"key":"R71-20250619","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2459\/JCM.0000000000000288","article-title":"Cardiac involvement in patients with cirrhosis: a focus on clinical features and diagnosis.","volume":"17","author":"Licata","year":"2016","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"R72-20250619","first-page":"1642; author reply 1642","article-title":"E\/A ratio alone cannot reliably diagnose diastolic dysfunction in the assessment before and after TIPS.","volume":"56","author":"Abeles","year":"2007","journal-title":"Gut"},{"key":"R73-20250619","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/gut.2006.102467","article-title":"Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt.","volume":"56","author":"Cazzaniga","year":"2007","journal-title":"Gut"},{"key":"R74-20250619","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccc.2016.02.004","article-title":"The circulatory system in liver disease.","volume":"32","author":"Hollenberg","year":"2016","journal-title":"Crit Care Clin"},{"key":"R75-20250619","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2125.1986.tb05174.x","article-title":"Alterations in isoprenaline sensitivity in patients with cirrhosis: evidence of abnormality of the sympathetic nervous activity.","volume":"21","author":"Ramond","year":"1986","journal-title":"Br J Clin Pharmacol"},{"key":"R76-20250619","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.23775","article-title":"Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites.","volume":"52","author":"Serst\u00e9","year":"2010","journal-title":"Hepatology"},{"key":"R77-20250619","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4330\/wjc.v9.i4.347","article-title":"QT prolongation is associated with increased mortality in end stage liver disease.","volume":"9","author":"Kim","year":"2017","journal-title":"World J Cardiol"},{"key":"R78-20250619","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.mayocp.2018.12.020","article-title":"Portal hypertension and related complications: diagnosis and management.","volume":"94","author":"Simonetto","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"R79-20250619","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1572-0241.2006.00453.x","article-title":"Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis.","volume":"101","author":"Turnes","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R80-20250619","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/apt.14576","article-title":"Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose-response study.","volume":"47","author":"Schwarzer","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"R81-20250619","doi-asserted-by":"crossref","first-page":"1680.e1","DOI":"10.1053\/j.gastro.2014.03.005","article-title":"Nonselective \u03b2 blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis.","volume":"146","author":"Mandorfer","year":"2014","journal-title":"Gastroenterology"},{"key":"R82-20250619","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jhep.2013.09.016","article-title":"The changing role of beta-blocker therapy in patients with cirrhosis.","volume":"60","author":"Ge","year":"2014","journal-title":"J Hepatol"},{"key":"R83-20250619","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/hep.23857","article-title":"Does cardiac dysfunction explain deleterious effects of beta-blockers in cirrhosis and refractory ascites?","volume":"53","author":"Krag","year":"2011","journal-title":"Hepatology"},{"key":"R84-20250619","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/gutjnl-2011-301348","article-title":"The window hypothesis: haemodynamic and non-haemodynamic effects of \u03b2-blockers improve survival of patients with cirrhosis during a window in the disease.","volume":"61","author":"Krag","year":"2012","journal-title":"Gut"},{"key":"R85-20250619","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/gut.2009.180570","article-title":"Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites.","volume":"59","author":"Krag","year":"2010","journal-title":"Gut"},{"key":"R88-20250619","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1001\/archinte.1986.00360230201029","article-title":"Paracentesis of ascitic fluid. A safe procedure.","volume":"146","author":"Runyon","year":"1986","journal-title":"Arch Intern Med"},{"key":"R89-20250619","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJM199402033300508","article-title":"Care of patients with ascites.","volume":"330","author":"Runyon","year":"1994","journal-title":"N Engl J Med"},{"key":"R90-20250619","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1056\/NEJM198912143212403","article-title":"Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. Veterans Administration Cooperative Study on Treatment of Alcoholic Cirrhosis with Ascites.","volume":"321","author":"Stanley","year":"1989","journal-title":"N Engl J Med"},{"key":"R91-20250619","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jacc.2013.04.070","article-title":"Abdominal contributions to cardiorenal dysfunction in congestive heart failure.","volume":"62","author":"Verbrugge","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R92-20250619","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/hep.24786","article-title":"Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials.","volume":"55","author":"Bernardi","year":"2012","journal-title":"Hepatology"},{"key":"R93-20250619","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.cardfail.2008.02.010","article-title":"Prompt reduction in intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure.","volume":"14","author":"Mullens","year":"2008","journal-title":"J Card Fail"},{"key":"R94-20250619","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4103\/0975-3583.70914","article-title":"Predictors of large volume paracantesis induced circulatory dysfunction in patients with massive hepatic ascites.","volume":"1","author":"Nasr","year":"2010","journal-title":"J Cardiovasc Dis Res"},{"key":"R95-20250619","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/eurjhf\/hfs013","article-title":"Continuous ambulatory peritoneal dialysis as a therapeutic alternative in patients with advanced congestive heart failure.","volume":"14","author":"N\u00fa\u00f1ez","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"R96-20250619","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jvir.2015.09.018","article-title":"Quality improvement guidelines for transjugular intrahepatic portosystemic shunts.","volume":"27","author":"Dariushnia","year":"2016","journal-title":"J Vasc Interv Radiol"},{"key":"R97-20250619","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1055\/s-0034-1382790","article-title":"Transjugular intrahepatic portosystemic shunt: indications, contraindications, and patient work-up.","volume":"31","author":"Copelan","year":"2014","journal-title":"Semin Intervent Radiol"},{"key":"R98-20250619","doi-asserted-by":"crossref","first-page":"100122","DOI":"10.1016\/j.jhepr.2020.100122","article-title":"Where does TIPS fit in the management of patients with cirrhosis?","volume":"2","author":"Garc\u00eda-Pag\u00e1n","year":"2020","journal-title":"JHEP Rep"},{"key":"R99-20250619","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/hep.20559","article-title":"The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.","volume":"41","author":"Boyer","year":"2005","journal-title":"Hepatology"},{"key":"R100-20250619","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1177\/0300060518782780","article-title":"Chronic heart failure in patients with nonalcoholic fatty liver disease: prevalence, clinical features, and relevance.","volume":"46","author":"Zhang","year":"2018","journal-title":"J Int Med Res"},{"key":"R101-20250619","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.clinre.2016.07.005","article-title":"Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases.","volume":"41","author":"Motamed","year":"2017","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R102-20250619","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/cld.721","article-title":"The association between nonalcoholic fatty liver disease and cardiovascular disease outcomes.","volume":"12","author":"Wong","year":"2018","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"R103-20250619","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/hep.23314","article-title":"Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.","volume":"51","author":"S\u00f6derberg","year":"2010","journal-title":"Hepatology"},{"key":"R104-20250619","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jhep.2016.04.005","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications.","volume":"65","author":"Francque","year":"2016","journal-title":"J Hepatol"},{"key":"R105-20250619","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study.","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"key":"R106-20250619","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"key":"R107-20250619","doi-asserted-by":"crossref","first-page":"389.e10","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease.","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"R108-20250619","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/hep.24127","article-title":"Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings.","volume":"53","author":"Brunt","year":"2011","journal-title":"Hepatology"},{"key":"R109-20250619","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"key":"R110-20250619","doi-asserted-by":"crossref","first-page":"e0135329","DOI":"10.1371\/journal.pone.0135329","article-title":"Nonalcoholic fatty liver disease is independently associated with early left ventricular diastolic dysfunction in patients with type 2 diabetes.","volume":"10","author":"Mantovani","year":"2015","journal-title":"PLoS One"},{"key":"R111-20250619","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/01.mcg.0000225668.53673.e6","article-title":"Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment.","volume":"40","author":"Goland","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"R112-20250619","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/hep.27869","article-title":"Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population-based study.","volume":"62","author":"VanWagner","year":"2015","journal-title":"Hepatology"},{"key":"R113-20250619","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.metabol.2015.04.003","article-title":"Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease.","volume":"64","author":"Mantovani","year":"2015","journal-title":"Metabolism"},{"key":"R114-20250619","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.atherosclerosis.2009.10.030","article-title":"Heart valve sclerosis predicts all-cause and cardiovascular mortality.","volume":"209","author":"V\u00f6lzke","year":"2010","journal-title":"Atherosclerosis"},{"key":"R115-20250619","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1161\/ATVBAHA.112.300556","article-title":"Hepatic steatosis is associated with aortic valve sclerosis in the general population: the Study of Health in Pomerania (SHIP).","volume":"33","author":"Markus","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R116-20250619","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.amjmed.2019.09.002","article-title":"Atrial fibrillation and heart failure with preserved ejection fraction in patients with nonalcoholic fatty liver disease.","volume":"133","author":"Packer","year":"2020","journal-title":"Am J Med"},{"key":"R117-20250619","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.amjcard.2012.09.021","article-title":"Relation of circulating liver transaminase concentrations to risk of new-onset atrial fibrillation.","volume":"111","author":"Sinner","year":"2013","journal-title":"Am J Cardiol"},{"key":"R119-20250619","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1210\/jc.2012-3093","article-title":"Clinical review: nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications.","volume":"98","author":"Targher","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R120-20250619","doi-asserted-by":"crossref","first-page":"e001820","DOI":"10.1161\/JAHA.115.001820","article-title":"Nonalcoholic fatty liver disease is associated with QT prolongation in the general population.","volume":"4","author":"Hung","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"R121-20250619","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jhep.2008.06.012","article-title":"Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review.","volume":"49","author":"Sookoian","year":"2008","journal-title":"J Hepatol"},{"key":"R123-20250619","doi-asserted-by":"crossref","first-page":"e004973","DOI":"10.1136\/bmjopen-2014-004973","article-title":"Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study.","volume":"4","author":"Pisto","year":"2014","journal-title":"BMJ Open"},{"key":"R124-20250619","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cgh.2011.12.039","article-title":"Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population.","volume":"10","author":"Stepanova","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R125-20250619","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.livres.2018.03.003","article-title":"Cytokines and fatty liver diseases. H. T, ed.","volume":"2","author":"Niederreiter","year":"2018","journal-title":"Liver Res"},{"key":"R126-20250619","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1365-2362.2010.02338.x","article-title":"Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease.","volume":"40","author":"Yilmaz","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"R127-20250619","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1210\/jc.2018-02414","article-title":"Plasma fibroblast growth factor 21 is associated with severity of nonalcoholic steatohepatitis in patients with obesity and type 2 diabetes.","volume":"104","author":"Barb","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"R128-20250619","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/ATVBAHA.113.301599","article-title":"Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors.","volume":"33","author":"Chow","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R130-20250619","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.26717","article-title":"Extrahepatic complications of nonalcoholic fatty liver disease.","volume":"59","author":"Armstrong","year":"2014","journal-title":"Hepatology"},{"key":"R131-20250619","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1530\/EJE-13-0296","article-title":"Non-alcoholic fatty liver disease in common endocrine disorders.","volume":"169","author":"Hazlehurst","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"R132-20250619","doi-asserted-by":"crossref","first-page":"8102","DOI":"10.3748\/wjg.v20.i25.8102","article-title":"Non-alcoholic fatty liver disease and thyroid dysfunction: a systematic review.","volume":"20","author":"Eshraghian","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R133-20250619","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s10620-011-2006-2","article-title":"Prevalence of hypothyroidism in nonalcoholic fatty liver disease.","volume":"57","author":"Pagadala","year":"2012","journal-title":"Dig Dis Sci"},{"key":"R134-20250619","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jhep.2012.02.027","article-title":"Non-alcoholic fatty liver disease across the spectrum of hypothyroidism.","volume":"57","author":"Chung","year":"2012","journal-title":"J Hepatol"},{"key":"R135-20250619","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fendo.2017.00335","article-title":"Relationship between hypothyroidism and non-alcoholic fatty liver disease: a systematic review and meta-analysis.","volume":"8","author":"He","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R136-20250619","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1196\/annals.1296.067","article-title":"Changes of noradrenergic activity and lipolysis in the subcutaneous abdominal adipose tissue of hypo- and hyperthyroid patients: an in vivo microdialysis study.","volume":"1018","author":"Nedvidkova","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"R137-20250619","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1172\/JCI60580","article-title":"Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy.","volume":"122","author":"Sinha","year":"2012","journal-title":"J Clin Invest"},{"key":"R138-20250619","doi-asserted-by":"crossref","first-page":"c7199","DOI":"10.1136\/bmj.c7199","article-title":"Hypothyroidism in a patient with non-alcoholic fatty liver disease.","volume":"342","author":"Gardner","year":"2011","journal-title":"BMJ"},{"key":"R139-20250619","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1210\/en.2011-1793","article-title":"Thyroid hormone receptor-\u03b1 gene knockout mice are protected from diet-induced hepatic insulin resistance.","volume":"153","author":"Jornayvaz","year":"2012","journal-title":"Endocrinology"},{"key":"R140-20250619","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis.","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"R141-20250619","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1053\/j.gastro.2015.04.014","article-title":"Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients.","volume":"149","author":"Lassailly","year":"2015","journal-title":"Gastroenterology"},{"key":"R142-20250619","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/hep.30368","article-title":"Vitamin E improves transplant-free survival and hepatic decompensation among patients with nonalcoholic steatohepatitis and advanced fibrosis.","volume":"71","author":"Vilar-Gomez","year":"2020","journal-title":"Hepatology"},{"key":"R143-20250619","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","article-title":"Current and future pharmacological therapies for NAFLD\/NASH.","volume":"53","author":"Sumida","year":"2018","journal-title":"J Gastroenterol"},{"key":"R144-20250619","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/hep.30603","article-title":"Letter to the Editor: will vitamin E be the hope of patients with NASH and advanced fibrosis? The reliability is worth discussing.","volume":"70","author":"He","year":"2019","journal-title":"Hepatology"},{"key":"R145-20250619","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12876-017-0652-3","article-title":"Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study.","volume":"17","author":"Honda","year":"2017","journal-title":"BMC Gastroenterol"},{"key":"R146-20250619","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.dld.2014.07.170","article-title":"The efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease.","volume":"47","author":"Pastori","year":"2015","journal-title":"Dig Liver Dis"},{"key":"R147-20250619","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/MCG.0000000000001260","article-title":"Statin use is protective against hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: a case-control study.","volume":"54","author":"German","year":"2020","journal-title":"J Clin Gastroenterol"},{"key":"R148-20250619","doi-asserted-by":"crossref","first-page":"1179552218787502","DOI":"10.1177\/1179552218787502","article-title":"An evidence-based review of statin use in patients with nonalcoholic fatty liver disease.","volume":"11","author":"Sigler","year":"2018","journal-title":"Clin Med Insights Gastroenterol"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000379","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T18:01:35Z","timestamp":1750356095000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000379"}},"subtitle":["A Relationship That Cuts Both Ways"],"short-title":[],"issued":{"date-parts":[[2020,12,17]]},"references-count":139,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000379","relation":{},"ISSN":["1061-5377"],"issn-type":[{"value":"1061-5377","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,17]]}}}